Tema ETFs’s Beam Therapeutics BEAM Stock Holding History

Tema ETFs’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$201K	Buy	+8,214	New	+$229K	0.01%	538

Other funds holding BEAM

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

CIM

Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return

BFS

Beacon Financial Strategies Raleigh, North Carolina $203M AUM 12.07% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Tema ETFs's BEAM Position: Q3 2026 in Review

Tema ETFs opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 8,214 shares worth $201K. The stake represents 0.01% of the portfolio and ranks #538 among its holdings.

17 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

Tema ETFs held 8,214 shares of Beam Therapeutics worth $201K as of Q3 2026.
Beam Therapeutics was a new Tema ETFs position in Q3 2026.
Beam Therapeutics made up 0.01% of Tema ETFs's portfolio in Q3 2026, its #538 holding.
17 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.